These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6762613)

  • 21. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The participation of phospholipids in blood coagulation].
    Zítko M
    Cesk Fysiol; 1979; 28(4):319-32. PubMed ID: 389461
    [No Abstract]   [Full Text] [Related]  

  • 23. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and localization of tissue factor-based procoagulant activity (PCA) in pigeon monocyte-derived macrophages.
    Gupta M; Doellgast GJ; Cheng T; Lewis JC
    Thromb Haemost; 1993 Dec; 70(6):963-9. PubMed ID: 8165619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum effects following tissue thromboplastin infusion.
    Astrup T; Albrechtsen OK
    Thromb Diath Haemorrh; 1969 Feb; 21(1):117-28. PubMed ID: 5773723
    [No Abstract]   [Full Text] [Related]  

  • 26. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipid requirements of tissue thromboplastin in blood coagulation.
    Liu DT; McCoy LE
    Thromb Res; 1975 Jul; 7(1):213-221. PubMed ID: 1154339
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe factor VII deficiency caused by a novel point mutation (Arg353Pro) combined with a rare Cys22Arg mutation.
    Zhidong W; Xiaojun H
    Thromb Haemost; 2007 Sep; 98(3):687-8. PubMed ID: 17849063
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for an essential role of tissue factor dependent blood coagulation in the pathogenesis of the local Shwartzman reaction.
    Zivelin A; Rao LV; Rapaport SI
    Blood Cells Mol Dis; 1995; 21(1):9-19. PubMed ID: 7655863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
    Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
    Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple method for determination of the factor VII-phospholipid complex using Normotest.
    Dalaker K; Janson TL; Johnsen B; Skartlien AH; Prydz H
    Thromb Res; 1987 Aug; 47(3):287-93. PubMed ID: 3629556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational transitions of thromboplastin apoprotein from pig brain.
    Howell RM; Rezvan H; Scopes PM
    FEBS Lett; 1979 Jan; 97(1):23-6. PubMed ID: 761618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.